WELCH, West Virginia (Reuters) - The opioid epidemic that has so far killed half a million Americans is routinely blamed on greedy drug makers, feckless doctors and lax regulators. But there’s another
(Reuters) - Acer Therapeutics Inc said on Tuesday its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture was declined approval from the U.S. Food and Drug Administration.
(Reuters) - Akorn Inc said on Tuesday the U.S. Food and Drug Administration has raised certain issues related to its Somerset, New Jersey manufacturing facility, sending the generic drugmaker’s shares
There have been some positive developments regarding the nation’s teenagers recently. Teens’ overall use of tobacco, alcohol, opioids and illicit drugs has declined significantly, in some cases to the
Anyone over 21, and with an ID to prove it, can purchase cigarettes, booze and even marijuana in retail establishments across San Francisco. But as soon as next month, one age-restricted product won’t
Here are some of the companies with shares expected to trade actively in Monday’s session. Stock movements noted by ticker reflect movements during regular trading hours; premarket trading is specified
(Reuters) - The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals’ drug to restore sexual desire in premenopausal women, the latest attempt to come up with a therapy
(Reuters) - Japan's Daiichi Sankyo Co said on Friday the U.S. Food and Drug Administration has declined to approve its drug quizartinib as a treatment for adults with a type of blood cancer. The decision